# To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

> clinical trial · VERIFIED · 2026-06-26

Status: ACTIVE_NOT_RECRUITING · Sponsor: Humacyte, Inc. · Condition: End Stage Renal Disease (ESRD)

- Company: Humacyte, Inc.
- Sector: medtech
- Primary source: https://clinicaltrials.gov/study/NCT05908084

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.